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This study examined the inhibitory effect of Stigmast-5-en-3-O-glucopyranosidetriacetate-
51-ol (SGTA), an isolate from petroleum ether extract of Cuscuta reflexa and performed
comparative study of petroleum ether extract (PTE), ethanolic extract (ETE) and SGTA on
hair growth activity in androgenic alopecia rat model. Alopecia induced in albino rats by
testosterone administration subcutaneously for 21 days. Finasteride solution was applied
topically served as standard. In vitro experiment to study the effect of extracts and isolate
on activity of 5a-reductase enzyme and comparing with finasteride. In vivo experiment
showed that rat follicular density and anagen/telogen (A/T) ratio were increased in the PTE,
ETE and SGTA treated group when compared to a control group. Skin histological results
shown that the PTE, ETE and SGTA treated group had an increase in number and shape of
the hair follicles and increase in the follicle anagen/telogen ratio when compared to the
finasteride and control group. The result indicated that the ethanolic, petroleum ether
extract and isolate of petroleum ether extract of C. reflexa found useful in the treatment of
androgen-induced alopecia in the experimental animal. In summary, SGTA and extract
control the apoptosis of hair cells and retarded the testosterone induce alopecia and
therefore be a natural product with much impending for use as a treatment for androgenic
alopecia.
Copyright 2014, Beni-Suef University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
The term androgenetic alopecia frequently used to express
the patterned loss of scalp hair in genetically vulnerable men4.
com (S. Patel).
i-Suef University.
ity. Production and hostiand women. Androgenetic alopecia (AGA) is an androgen-
driven condition in genetically prone individuals that affects
half of the male population (Otberg et al., 2007). There are
various genetic and environmental factors, which are engaged
in causing AGA. In androgenetic alopecia miniaturization ofng by Elsevier B.V. All rights reserved.
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affected region, that is mainly drive by androgen. The key
androgen is supposed to be an active metabolite of testos-
terone called dihydrotestosterone, rather than testosterone
itself. The 5a-reductase type-2 isoenzyme is mainly respon-
sible catalyst for the conversion of testosterone into dihy-
drotestosterone because of this it is main target for treatment
of alopecia (Sinclair, 2005).
Presently available therapies for treatment and manage-
ment of androgenetic alopecia are antiandrogens and biolog-
ical response modifiers. On the other hand, the low success
rate and related adverse effects confines their clinical use
(Price, 1999). Nowadays natural products consider in cos-
metics and about many kinds of extracts from plant investi-
gated for hair growth activity. Various plants and herbal
formulations reported as hair growth promoter aswell as used
for enhancement of hair quality in traditional Indian system
of medicine, but being deficient in sound scientific support
and information confines their use (Roy et al., 2005).
C. reflexa Roxb belongs to family Convolvulaceae. It is a
parasite, perennial herbs with slender long yellow or golden
stems. It is also called as dodder or akashabela or amarabela or
swarnalata. It is widely distributed in tropical and temperate
regions and common in all over India andCeylon. It depends on
host plants, mostly thorny herbs for growth and nutrition and
sometimes entirely covering the bushes and trees (Dorr, 1990;
Patel et al., 2012). Conventionally, it is mainly use as a purga-
tive in the management of protracted fever, diaphoretic, and
demulcent (Chopra et al., 1992; Kritikar and Basu, 1984). Anti-
steroidogenic properties ofmethanolic extract of C. reflexa have
been reported (Gupta et al., 2003). In our earlier study, we re-
ported the hair growth promotion of the petroleum ether
extract of this herb on denuded skin surface of albino (Roy et al.,
2006, Pandit et al., 2008). The present study, our investigation
was an attempt to compared the efficacy of petroleum ether
(PTE), ethanolic extract (ETE) and Stigmast-5-en-3-O-glucopyr-
anosidetriacetate-51-ol (SGTA), an isolate frompetroleum ether
extract of C. reflexa for promoting hair growth in testosterone-
induced hair loss and to showed that the ETE and SGTA also
inhibits conversion of testosterone to its more potent metabo-
lite, dihydrotestosterone by inhibiting 5a-reductase type 2 en-
zymes thus inhibiting hair loss as PTE.Fig. 1 e Stigmast-5-en-3-O-glucopyranosidetriacetate-51-
Ol.2. Materials and methods
2.1. Plant material and authentication
Stems of C. reflexa growing on Bougainvillea spectabilis and
Jasminum multiforum were collected in the month of NoveDec
2010 from forests surrounding our university campus, Sagar
and were authenticated by Dr. P.K Tiwari, Department of
Botany, Dr. H.S.Gour University (Herbarium no. Bot/Her/2123).
The plant material dried in sunlight and reduced to a coarse
powder.
2.2. Extraction
Coarsely powdered stems of C. reflexa feed in a soxhlet appa-
ratus and extracted with petroleum ether (60e80 C) and withethanol (95%) in separate assemblies to obtain petroleum
ether extract and ethanolic extract respectively.
2.3. Chromatographic characterization
C. reflexa is a parasitic plant that draws its nutrients from the
host. Phytoconstituents expected to show a discrepancy with
the host, and it is accordingly desirable thatmaterial collected
from the recognized host. For the present study, stems of C.
reflexa collected from plants growing on the B. spectabilis and
Jasminum multiforum. The Petroleum ether extract and etha-
nolic extract characterized by thin layer chromatography
(TLC) on precoated silica developed in toluene/ethyl acetate
(97: 3) and Chloroform: Methanol (9:1) as mobile phase
respectively. The plates sprayed with anisaldehyde sulfuric
acid reagent and heating at 105 C for 10 min gave eight and
four spot respectively.
2.4. Isolation, purification, and characterization of
active compound
The isolation of compound done based on solubility. For
isolation, the petroleum ether extract suspended in acetone
and shaken strongly to dissolve the extract. The insoluble
mass centrifuged at 2000 rpm, collected, and suspended into
ethyl acetate later than this it separated into ethyl acetate
soluble and insoluble fraction. Then, concentrated the ethyl
acetate soluble fraction and it yielded yellowish white solid
crystalline material after keeping in a refrigerator for about
12 h. It was further purified by crystallization; the isolated
compound SGTAmelted at 120 C and gave an Rf value of 0.83.
In solvent system toluene: ethyl acetate (97: 3) it gave a single
spot. It gave Lieberman burchard test and positive Salwonski
test that confirms the sterols moiety. Based on IR, NMR and
mass spectroscopic data it confirms the presence of steroidal
molecule (Fig. 1).
2.5. In vivo studies on hair growth
2.5.1. Animals
Male Swiss albino rats (6e8 months age, 130e140 g weight)
used. The animals were adapted to conventional laboratory
conditions with providing standard food and water. The
photoperiod kept at 12 h of light and 12 h of darkness and
temperature (25 ± 3 C). All animal experimentation carried
out after approval of the protocol by the Institutional Ethical
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CPCSEA (India) strictly followed.
2.5.2. Solutions
The vehicle used for dissolving the extracts, the isolate and
the standard (Finasteride) was ethanol, propylene glycol and
water (8:1:1). Testosterone administered as 1% solution in
arachis oil. The concentration of petroleum ether, ethanol
extract and Finasteride was 2% in the vehicle solution. The
isolate used as 0.5% suspension in the vehicle. Another sus-
pension of mixture of isolate and phosphatidylcholine (PC)
(50-50%) in vehicle at concentration of 0.5% were prepared.
2.5.3. Treatment
Animals divided into 6 groups of four rats each. The following
treatment given to animals of different groups:
Group I: Testosterone solution (s.c.) þ Vehicle (Topically)
Group II: Testosterone solution (s.c.) þ Finasteride solution
(2%) (Topically)
Group III: Testosterone solution (s.c.) þ Petroleum ether
extract solution (2%) of C. reflexa (Topically)
Group IV: Testosterone solution (s.c.) þ Ethanolic extract
solution (2%) of C. reflexa (Topically)
Group V: Testosterone solution (s.c.) þ Isolate suspension
(0.5%) (Topically)
Group VI: Testosterone solution (s.c.) þ Isolate and PC
mixture (50-50-%) (0.5% suspension) (Topically)
The method reported by Matia's was followed with minor
alteration (Matias et al., 1989, Pandit et al., 2008). Rats in all
groups were administered testosterone subcutaneously
(0.1 ml) daily. Animals of groups I, II, III, IV, V and VI were
given topical application of vehicle, finasteride, petroleum
ether extract, ethanolic extract, isolate and mixture of
isolate þ PC respectively.
Approximately 0.2 ml of the solution or vehicle topically
applied on back skin once a day for 20 days. On 21st days, rat
from each group selected randomly and sacrificed. The dif-
ference in growth of hair in each group noticed by visual
observation and recorded by taking photographs. Skin biopsy
also undertaken from the balding site of each group of rats,
and samples of skin kept in phosphate-buffered formalin for
paraffin sectioning. The cyclic phase of hair follicles (anagenTable 1 e Hair follicular density and A/T ratio in sections of sk
S.No. Group no. Treatment
1. I Testosterone (s.c)þ vehicle (topical) (Control)
2. II Testosterone (s.c)þ 2% Finasteride solution (to
3. III Testosterone (s.c)þ 2% Petroleum Ether Extrac
(topical)
4. IV Testosterone (s.c)þ 2% Ethanolic Extract of C.
5. V Testosterone (s.c)þ 0.5% suspension of Isolate
6. VI Testosterone (s.c)þ 0.5% suspension of Mixtur
Value are mean ± SD, n ¼ 12.
P < 0.001*, P < 0.05**, P < 0.01***, significance versus control.
(A/T ratio: Anagen/Telogen ratio; S.C: Subcutaneous; PC: Phosphatidylchoand telogen), number of hair follicles were determined, and
the anagen/telogen ratio was calculated with the help of
ocular micrometer (Table 1).
2.6. In-vitro studies on enzymatic activity
2.6.1. Enzyme preparation
Dihydrotestosterone (DHT) plays an active responsibility in
development and progression of Androgenetic Alopecia,
prostate cancer, benign prostatic hyperplasia. Therefore, 5a-
reductase enzyme is supposed to be in a larger quantity in
prostate. Adult male goat prostate (7.5 gm) was homogenate
with 30 ml of 20 mM sodium phosphate buffer solution at pH
6.5 containing 250 mmol/L of sucrose and 1 mmol/L of EDTA.
The homogenate centrifuged at 5000 rpm for 20 min and su-
pernatant taken as a source of enzyme (Pandit et al., 2008).
The fresh suspension used during the reaction. Bradford
method used to determine the concentration of enzyme in the
suspension (Bradford, 1976).
2.6.2. Preparation of test materials
Testosterone (10 mg/ml), extracts (8.5 mg/ml), isolate (5 mg/
ml) and finasteride (10 mg/ml) solution were prepared in
ethanol (95%) with gentle heating wherever necessary. The
EDTA solution (10 mg/ml) was prepared in distilled water.
2.6.3. Determination of optimum concentration of enzyme
It determined by keeping the concentration of substrate con-
stant and varying the concentration of enzyme. Optimum
concentration of enzyme is the point at which it attained
highest velocity and highest free enzyme able to interact with
substrate or at which enzyme demonstrate maximum
activity.
Reactionmixture (1ml)¼ Sodiumphosphate Buffer (40mM
at pH 6.5) þ Testosterone solution (1 mg or 0.1 ml) þ Enzyme
solution (0.1e0.9 ml).
The reaction mixture incubated at 37 C for 1 h and adding
2 ml ethyl acetate terminated the reaction. The mixture
shaken vigorously for 1 min and the ethyl acetate layer
separated. These layers evaporated to dryness, and the res-
idue then dissolved in 2 ml methanol. The methanolic solu-
tion followed by used for estimation of testosterone by high
performance liquid chromatography (HPLC; Shimadzu, Col-
umn C 18).in of different groups of animals.
Hair follicular
density (no./mm)
Anagen to
Telogen
1.5 ± 0.90 1:3.16
pical) 3.3 ± 0.77* 1.22:1
t of C. reflexa solution 2.5 ± 1.0** 1.6:1
reflexa solution (topical) 2.41 ± 0.90** 1.5:1
of C. reflexa (topical) 2.91 ± 0.79*** 1.63:1
e of Isolate and PC (topical) 3.25 ± 0.62* 1.85:1
line).
b e n i - s u e f un i v e r s i t y j o u rn a l o f b a s i c a n d a p p l i e d s c i e n c e s 3 ( 2 0 1 4 ) 1 6 5e1 7 11682.6.4. Determination of inhibitory concentrations of extract
and isolate
The reaction mixture (1.5 ml) made by adding testosterone
solution (0.1 ml), EDTA solution (0.1 ml), extracts/isolate/fi-
nasteride solutions (0.1e0.5 ml) for separate groups, optimum
amount of enzyme solution (i.e., 0.6 ml), and sodium phos-
phate (20 mm) to a final volume of 1.5 ml. Reaction mixture
incubated at 37 C for 60 min and reaction terminated by
addition of 3ml of ethyl acetate. Themixture was vortexed for
1 min; ethyl acetate layer separated and evaporated to dry-
ness. The residue dissolved in methanol and volumemade up
to 2 ml with methanol. HPLC used to determine the residual
testosterone content in methanol. The column was eluted
isocratically with amobile phase of methanol/water (80: 20) at
a flow rate of 1.0 ml/min (Purdon and Lehman, 1997).2.7. Statistical analysis
All data presented as MEAN ± SD of at least three samples.
Significant difference among groups determined using graph
pad instat version 2 for windows.Fig. 2 e Comparison of baldness pattern in each group. (A) Anim
alopecia. (B) Animal treated with testosterone and finasteride s
and petroleum ether extract showing less hair loss. (D) Animal t
hair loss. (E) Animal treated with testosterone and isolate show
mixture of isolate and PC showing less hair loss. (PC: Phosphat3. Results
The herb in the present studies selected based on its use in
traditionalmedicines for hair care. Stem of C. reflexa evaluated
during present investigations. Based on in-vitro method re-
sults petroleum ether, ethanolic extract and isolate of C.
reflexa tested in Testosterone induced alopecia model.3.1. Extraction
The yield in the case of petroleum ether extraction was 3.0%
w/w whereas 3.6% w/w in the case of ethanolic extraction.
This recorded on elimination of solvent under reduced pres-
sure and weighing its residue.3.2. In vivo studies on hair growth
3.2.1. Morphologic observation
The animals of groups I showed diffuse alopecia. Loss of hair
from the dorsal portion of rats was clearly visible after 20 days
of treatment with testosterone (Fig. 2A). In animals of groupal treated with testosterone and vehicle showing diffuse
howing less hair loss. (C) Animal treated with testosterone
reated with testosterone and ethanolic extract showing less
ing less hair loss. (F) Animal treated with testosterone and
idylcholine).
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andmixture of isolate and PC respectively administered along
with testosterone. The alopecic condition was not visible in
this group of animals, showing that the extracts and isolate
prevented the action of testosterone and blocked
testosterone-induced hair loss (Fig. 2C, D, E, F). The observa-
tion was the same in animals of group II who received finas-
teride along with testosterone (Fig. 2B).
3.2.2. Histological observation
Histology of skin sections of group I animals shown that
testosterone treatment caused miniaturization of hair folli-
cles. Follicles of group-I showed characteristics of telogen
follicles i.e. smaller in length, hollow, presence of necrosis,
more destroyed follicles, follicle shrinks means diameter de-
creases and not deeper. Several hair follicles were in the tel-
ogen phase (Fig. 3A). The effect of testosterone on
miniaturization of hair follicle was inhibited by administra-
tion of petroleum ether extract, ethanolic extract, isolate and
mixture of isolate and PC in-group III, IV, V and VI animals
respectively. The increase in number of hair follicles noted.
The number of follicles in anagen phase was considerably
increased and fewer follicles in telogen phase observed. Fol-
licles of group-II, group-III, group-IV, group-V, and group-VI
showed characteristics of anagen follicles i.e. Follicle hair
longer in length follicles dense (number increases as
compared to group I), less cell necrosis, and present deeper
(Fig. 3B, C, D, E, F). In-group V and group VI number of follicle
are more than group III and group IV. There was no significant
change in epidermis and dermis cells. Again, the number of
follicles in hair growth phase increased with duration ofFig. 3 e Photomicrograph of skin of animal in each group (A) Skin
animal treated with testosterone and Finasteride solution. (C) Sk
extract solution. (D) Skin of animal treated with testosterone an
testosterone and Isolate suspension. (F) Skin of animal treated
Phosphatidylcholine; HF: Hair Follicle).treatment. The Hair follicular density and anagen telogen
ratio (A/T ratio) was calculated (Table 1).
3.2.3. Hair follicular density
The histological study showed that hair density was
maximum i.e. 3.3 ± 0.77 in case of standard, 3.25 ± 0.62 in case
of mixture of Isolate and PC treated, 2.91 ± 0.79 in case of
Isolate treated, 2.5 ± 1 in case of petroleum ether extract
treated, 2.41 ± 0.90 in case of ethanolic extract treated while it
was minimum i.e. 1.5 ± 0.90 in testosterone and vehicle
treated animals (Table 1).
3.2.4. Anagen telogen ratio (A/T ratio)
A/T ratio was maximum i.e. 1.85:1 in case of mixture of Isolate
and PC treated, 1.63:1 in case of Isolate treated, 1.6:1 in case of
petroleum ether extract treated, 1.5:1 in case of ethanolic
extract treated, 1.22:1 in case of standard treated while it was
minimum i.e. 1: 3.16 in testosterone and vehicle treated ani-
mals (Table 1).
The prostate gland weight found to be 0.1094 g, 0.0992 g,
0.1044 g, 0.0995 g, 0.1065 g and 0.0981 g of animal treated with
Testosterone and vehicle, Finasteride, petroleum ether
extract, ethanolic extract, Isolate and mixture of Isolate and
PC respectively. Negligible change in prostate weights
observed during in vivo studies (Table 2).
3.3. Determination of IC 50
The optimum amount of enzyme solution to give optimum
activity found to be 0.60 ml (213.72 mg enzyme fraction).
Varying concentrations of test substances incubated with aof animal treated with testosterone and Vehicle. (B) Skin of
in of animal treated with testosterone and petroleum ether
d ethanolic extract solution. (E) Skin of animal treated with
with testosterone and mixture of isolate and PC. (PC:
Table 2 eWeight of prostate gland of animals of different groups.
S. No. Group No. Treatment Weight of prostate (g)
1. I Testosterone (s.c)þ vehicle (topical) 0.1094 ± 0.002
2. II Testosterone (s.c)þ 2% Finasteride solution (topical) 0.0992 ± 0.001
3. III Testosterone (s.c)þ 2% Petroleum Ether Extract of C. reflexa solution
(topical)
0.1044 ± 0.006
4. IV Testosterone (s.c)þ 2% Ethanolic Extract of C. reflexa solution (topical) 0.0995 ± 0.007
5. V Testosterone (s.c)þ 0.5% suspension of Isolate of C. reflexa (topical) 0.1065 ± 0.001
6. VI Testosterone (s.c)þ 0.5% suspension of Mixture of Isolate and PC (topical) 0.0981 ± 0.003
Values are mean ± SD, n ¼ 3.
(S.C: Subcutaneous; PC: Phosphatidylcholine).
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mixture, and the residual testosterone content was deter-
mined after termination of reaction with ethyl acetate. The
residual testosterone content in reaction mixture increased
with increasing concentration of ethanolic extract of C. reflexa,
isolate, and finasteride. The IC50 values of extracts, isolate and
Finasteride were determined from inhibition curves and
stated as 1.06 mg/ml for petroleum ether extract, 1.51 mg/ml
for ethanolic extract, 0.76mg/ml for isolate and 1.81mg/ml for
Finasteride, providing enzyme inhibitory activity of these
compounds.
The testosterone induced alopeciamodel was successful in
bringing for the activities of test extracts. The relative efficacy
of different material was as follows:
Mixture of Isolate from C. reflexa and PC > Isolate from C.
reflexa > Petroleum ether extract of C. reflexa > Ethanolic
extract of C. reflexa.
4. Discussion
Androgens are mediators of terminal hair growth all through
the body. Androgenetic alopecia (AGA) is a dihydrotestoster-
one (DHT)-mediated process, characterized by continuous
miniaturization of androgen reactive hair follicles and
accompanied by perifollicular fibrosis of follicular units in
histological assessment (Yoo et al., 2006). Alopecia induced in
rat by administration of testosterone. Dihydrotestosterone,
which is a more potent androgen than testosterone, results in
miniaturization of hair follicle and change in cyclic phase of
hair growth cycle, which leads to androgenic alopecia. In
balding men, DHT binds to androgen receptors in vulnerable
hair follicles and, by an unknownmechanism, activates genes
liable for follicular miniaturization. Both plucked follicles and
skin from balding scalp revealed to contain increased levels of
DHT compared to follicles and skin from non-balding scalp.
For the conversion of testosterone to dihydrotestosterone, 5a-
reductase type 2 enzyme is responsible (Kaufman, 2002). Fi-
nasteride, a synthetic anti-androgenic drug, marketed for hair
growth, and the mechanism involved is inhibition of 5a-
reductase activity.
Alopecia in the AGA rat occurs because androgens induce a
decline in the rate of hair growth and markedly prolongs the
duration the resting phase or telogen. That is the reason for
more telogen follicle in control group I. The alopecia, inducedin the rat by testosterone, counteracted when extracts and
isolate administered simultaneously to the rat. The alopecia
not observed in groups treated with extracts or isolate or fi-
nasteride along with testosterone and anagen follicles are
more than telogen follicles because of retention of late ana-
genic follicles as well as increase in follicular length and pre-
vention of their miniaturization may therefore attributed due
to 5a-reductase inhibitory activity. Besides visual observation,
quantitative data (e.g., A/T ratio and follicular density) also
suggested inhibition of androgenic activity of the extract.
Result of in-vitro studies showed that these extracts and
isolate also inhibit 5a-reductase enzyme activity as
finasteride.
Phospholipids i.e. phosphatidylcholine (PC) play a major
role in drug delivery technology. There are abundant advan-
tages of phospholipids in addition to solubilizing property
while taking into consideration them for a carrier system
(Upadhyay et al., 2012). Among the treated group, maximum
activity shown by group VI, in this group PC increases ab-
sorption of isolate and other group exhibited comparable or
better hair growth than finasteride treated group. The pre-
dominance of hair follicle in anagenic growth phase indicates
reversal of androgen induced hair loss in extracts, isolate and
finasteride treated group.
The prostate is affluent in enzyme 5a-reductase type 2, and
prostate homogenate demonstrates conversion of testos-
terone to dihydrotestosterone in reaction mixtures (Steers,
2001). The in-vitro study demonstrated 5a-reductase inhibi-
tory activity and reduction of conversion of testosterone to
DHT. Increased testosterone level in reaction mixture was
because of inhibition of 5a-reductase because it is not con-
verted to its metabolite dihydrotestosterone. Addition of
ethanolic extract, petroleum ether extract and isolate of C.
reflexa as well as finasteride in reaction mixture showed
increased levels of unchanged testosterone levels in reaction
mixture, suggesting inhibition of enzyme action by these test
materials.
In testosterone-induced alopecia, plant extracts have safe
topical effect. As negligible change in prostate weights,
observed during this study. This suggests that dose given by
topical applications were not sufficient to inhibit 5a-reductase
in prostate and only inhibition caused in skin 5a-reductase. A
hair growth promoter should have high anagen to telogen
ratio, high follicular density. Therefore, it can said that the
petroleum ether extract of C. reflexa Roxb, isolate from petro-
leum ether extract of C. reflexa and ethanolic extract of Cuscuta
reflexa plant can be used as hair growth promoter in
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reductase enzyme.5. Conclusion
It can concluded that C. reflexa petroleum ether extract,
ethanolic extract and its isolate from petroleum ether extract
i.e. Stigmast-5-en-3-O-glucopyranosidetriacetate-51-ol can be
used as a hair growth-promoting agent in androgenetic alo-
pecia, which is caused by an increase in androgen levels in the
skin. It also revealed that isolate has maximum efficacy than
extracts and petroleum ether extract have better effect than
ethanolic extract. Other androgen-dependent conditions like
benign prostatic hyperplasia, prostatic cancer and acne were
also due to dihydrotestosterone (Perez-Ordeals et al., 2005).
The observed 5a-reductase inhibitory activity of the extract
and its isolate makes them potential candidates worthy of
further investigation in management of these conditions.
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